Pharma & drug development – Journalist portfolio

Pharma & drug development

The rise of fake medicines in Africa

Pharma & drug development

Q&A: Gavi alliance talks immunising 300 million people

Pharma & drug development

Recurrent miscarriage: could this devastating condition have a simple cure?

Pharma & drug development

A safer ride: the latest innovation in targeted cancer treatment

Pharma & drug development

The problem of manipulated data

Pharma & drug development

Why is pharma so bad at sharing clinical trial information?

Pharma & drug development

Q&A: an eye on innovation with SparingVision

Business & finance Pharma & drug development

From start-ups to the SIX Swiss Exchange – a Swiss success story

Pharma & drug development

ConcePTION: tackling the unknowns of medication in pregnancy

Pharma & drug development

Understanding drug-resistant TB

Pharma & drug development

How do cancer cells communicate and can it help us catch them?

Pharma & drug development

Proteomics and the promise of ‘enriching’ clinical trials

Pharma & drug development

Is growth factor protein the future of Parkinson’s treatment?

Mental health Pharma & drug development

The drugs fighting memory loss

Pharma & drug development War on drugs

Medical cannabis in the UK: how has the roll out gone so far?

Pharma & drug development War on drugs

Thumbs up for esketamine

Pharma & drug development

Access to antivenom needs attention

Pharma & drug development

Developing a new class of cancer combo drugs

Pharma & drug development

Is a lack of female participants skewing heart disease trial results?

Pharma & drug development Science & tech

Category: Pharma & drug development

The rise of fake medicines in Africa

Q&A: Gavi alliance talks immunising 300 million people

Recurrent miscarriage: could this devastating condition have a simple cure?

A safer ride: the latest innovation in targeted cancer treatment

The problem of manipulated data

Why is pharma so bad at sharing clinical trial information?

Q&A: an eye on innovation with SparingVision

From start-ups to the SIX Swiss Exchange – a Swiss success story

ConcePTION: tackling the unknowns of medication in pregnancy

Understanding drug-resistant TB

How do cancer cells communicate and can it help us catch them?

Proteomics and the promise of ‘enriching’ clinical trials

Is growth factor protein the future of Parkinson’s treatment?

The drugs fighting memory loss

Medical cannabis in the UK: how has the roll out gone so far?

Thumbs up for esketamine

Access to antivenom needs attention

Developing a new class of cancer combo drugs

Is a lack of female participants skewing heart disease trial results?

Using AI to personalise drug combination therapy